A phase Ib randomized, double-blind, positive-parallel controlled trial to evaluate the efficacy, safety, and pharmacokinetic characteristics of HYR-PB21 paravertebral nerve block for injection for analgesia in patients with postherpetic neuralgia (PHN)
RecruitingChiCTR2100043823
The Second Xiangya Hospital of Central South UniversityPeripheral nerve block
Start: 2021-03-31Updated: 2021-07-05